34 results on '"Nazzari, Elena"'
Search Results
2. Iodoprophylaxis and thyroid autoimmunity: an update
3. Neuroendocrine Tumours: Diagnosis, Therapy and Follow-up
4. The Molecular Biology of NET: Current Status and Evaluation of Biomarkers for Prediction and Prognosis
5. ATTIVITÀ DI CONSERVAZIONE DAL 1 GENNAIO AL 31 DICEMBRE 2018
6. Fifteen Years of Iodine Prophylaxis in Italy: Results of a Nationwide Surveillance (Period 2015-2019)
7. ATTIVITÀ DI CONSERVAZIONE DAL 1 GENNAIO AL 31 DICEMBRE 2017
8. Nutrizione iodica e autoimmunità tiroidea: un prezzo da pagare?
9. Fifteen Years of Iodine Prophylaxis in Italy: Results of a Nationwide Surveillance (Period 2015-2019)
10. ATTIVITÀ DI CONSERVAZIONE DAL 1 GENNAIO AL 31 DICEMBRE 2016
11. Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives
12. ATTIVITÀ DI CONSERVAZIONE DAL 1 LUGLIO 2014 AL 31 DICEMBRE 2015
13. The Molecular Biology of NET: Current Status and Evaluation of Biomarkers for Prediction and Prognosis
14. Impact of pre-treatment with somatostatin analogs on surgical management of acromegalic patients referred to a single center
15. Trabecular Bone Score as a Reliable Measure of Lumbar Spine Bone Microarchitecture in Acromegalic Patients
16. Clinical outcome and evidence of high rate post-surgical anterior hypopituitarism in a cohort of TSH-secreting adenoma patients: Might somatostatin analogs have a role as first-line therapy?
17. Le terapie combinate nell’acromegalia: pro e contro: Proposto da Renato Cozzi
18. Polycythemia as rare secondary direct manifestation of acromegaly: management and single-centre epidemiological data
19. Obesity and Monitoring Iodine Nutritional Status in Schoolchildren: is Body Mass Index a Factor to Consider?
20. Diabetic Hepatosclerosis Presenting With Severe Cholestasis
21. Cardiovascular complications in pituitary gigantism (results of an international study)
22. P3.02c-039 Endocrinological Side-Effects of Nivolumab in Advanced Non-Small Cell Lung Cancer
23. T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly.
24. Unexpected Elevated Free Thyroid Hormones in Pregnancy
25. T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly
26. Bile duct lesions in diabetic hepatosclerosis could explain raised ALP and GGT in diabetic patients
27. Impact of pre-treatment with somatostatin analogs on surgical management of acromegalic patients referred to a single center
28. Clinical outcome and evidence of high rate post-surgical anterior hypopituitarism in a cohort of TSH-secreting adenoma patients: Might somatostatin analogs have a role as first-line therapy?
29. Faculty Opinions recommendation of Acromegaly has a negative influence on trabecular bone, but not on cortical bone, as assessed by high-resolution peripheral quantitative computed tomography.
30. Faculty Opinions recommendation of Discordant growth hormone and IGF-1 levels post pituitary surgery in patients with acromegaly naïve to medical therapy and radiation: what to follow, GH or IGF-1 values?
31. Faculty Opinions recommendation of Fat content in liver and skeletal muscle changes in a reciprocal manner in patients with acromegaly during combination therapy with a somatostatin analog and a GH receptor antagonist: a randomized clinical trial.
32. Faculty Opinions recommendation of Comparison of primary octreotide-lar and surgical treatment in newly diagnosed patients with acromegaly.
33. Polycythemia as rare secondary direct manifestation of acromegaly: management and single-centre epidemiological data
34. Role of Dopamine Receptors in Normal and Tumoral Pituitary Corticotropic Cells and Adrenal Cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.